Home
Storia in 1 fonti
Fatal gene-editing trial in China raises ethics and oversight questions
Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout
Raccontata da
statnews.com
Timeline cronologica
- ·
Pharma tries to tamp down broad China restrictions
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The Readout
- ·
FDA panel confronting peptide controversy
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."
- ·
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
- ·
Fatal gene-editing trial in China raises ethics and oversight questions
Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout